Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2022 | Cognitive involvement in MS – the importance

Leigh Charvet • 26 Feb 2022
ACTRIMS 2022
Multiple Sclerosis and Related Disorders

Leigh Charvet, PhD, New York University Grossman School of Medicine, New York, NY, talks about cognitive involvement in multiple sclerosis (MS) and how it proves to be a major impairment towards many patients who suffer from the disease. Being a common symptom in the MS community, issues with everyday life are expected – leading to the need to develop further home-based, accessible treatments for those affected. This interview took place at the ACTRIMS Forum 2022 in West Palm Beach, Florida.

Disclosures

Prof. Charvet reports the following disclosures:
Funding: US Department of Defense & National Multiple Sclerosis Society

More from Leigh Charvet

Navigating intra-individual variability for early detection of cognitive decline
3:44
Navigating intra-individual variability for early detection of cognitive decline
Leigh Charvet • 23 Feb 2024
RECOVER-NEURO: testing cognitive function interventions for long-COVID
2:51
RECOVER-NEURO: testing cognitive function interventions for long-COVID
Leigh Charvet • 23 Feb 2024
Transcranial direct current stimulation to decrease cannabis use in MS
5:12
Transcranial direct current stimulation to decrease cannabis use in MS
Leigh Charvet • 23 Feb 2024
Developments in teleinterventions: tDCS with remote supervision for MS rehabilitation
9:21
Developments in teleinterventions: tDCS with remote supervision for MS rehabilitation
Giuseppina Pilloni et al. • 13 Apr 2022

Related Videos

What are the key changes introduced in the 2024 revision of the McDonald diagnostic criteria for MS?
6:48
What are the key changes introduced in the 2024 revision of the McDonald diagnostic criteria for MS?
Mar Tintoré • 3 Jul 2026
Ovarian aging and long-term prognosis in women with multiple sclerosis
3:07
Ovarian aging and long-term prognosis in women with multiple sclerosis
Mar Tintoré • 3 Jul 2026
The emerging role of AI in the diagnosis and management of multiple sclerosis
1:55
The emerging role of AI in the diagnosis and management of multiple sclerosis
Celia Oreja-Guevara • 29 Jun 2026
Can selected patients with multiple sclerosis safely discontinue ocrelizumab?
3:15
Can selected patients with multiple sclerosis safely discontinue ocrelizumab?
Franz Felix Konen • 28 Jul 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals